tirzepatide off the shortage list The FDA says it's standing by its earlier decision that the Semaglutide and Tirzepatide No Longer

This decision is based on the improved availability of the brand-name medication, ensuring that patients receive FDA-approved drugs that have undergone rigorous safety and efficacy reviews4

Understand Payer-Specific Rules Medicare, Medicaid, and private insurers may flag R73.9 if not supported by adequate documentation

Its so easy to use just once a week, and I can eat whatever I want, while still automatically controlling my portions

Appetite is driven by hormones, and semaglutide works on those hormones directly

Tirzepatide acts on two hormone pathways (GLP-1 and GIP) rather than just one which might help explain why tirzepatide has produced greater average weight loss in some studies

TripleHormone-Receptor Agonist Retatrutide for Obesity Most frequent side effects were gastrointestinal symptoms like nausea, vomiting, diarrhoea, and constipation